Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_provenance.
- NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_assertion description "[Molecular therapeutic approaches, for example, those directed against the fusion protein BCR-ABL with ABL-tyrosine kinase inhibitor, are on the way to creating a new avenue for the treatment of ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_provenance.
- NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_assertion evidence source_evidence_literature NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_provenance.
- NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_assertion SIO_000772 11049022 NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_provenance.
- NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_assertion wasDerivedFrom befree-2016 NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_provenance.
- NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_assertion wasGeneratedBy ECO_0000203 NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_provenance.
- befree-2016 importedOn "2016-02-19" NP298417.RA9nW_UzJ4diPY4SXyZxKV_1NH5nhp4ZKySk9HH2_pCPI130_provenance.